Hepatitis Clinical Trials

Showing 281-300 of 1,819 trials

Study of VIR-3434 in Healthy Volunteers and Patients With Chronic Hepatitis B Virus Infection

NCT04423393

This is a Phase 1 study in which healthy volunteers and participants with chronic HBV infection will receive VIR-3434 or placebo and will be assessed for safety, tolerability, pharmacokinetics (PK), and antiviral activity (only in participants with chronic HBV infection).

Chronic Hepatitis B

Vir Biotechnology, Inc.113 participantsStarted May 2020

Essen, Germany • Frankfurt, Germany • Hanover, Germany +21 more locations

Not Yet Recruiting

Treatment Prioritisation and Cost-Effectiveness Analysis for HBV Cure - Real-World Evidence from a Territory-Wide Cohort

NCT06627608

A number of hepatitis B virus (HBV) cure regimens including antisense oligonucleotide (ASO) and small interfering RNA (siRNA) are under vigorous clinical development and the efficacy and safety will soon be available for regulatory approval. Patients most in need should be prioritised to receive HBV cure regimen to maximise its clinical benefits and speed up hepatitis elimination.

Chronic Hepatitis B

Chinese University of Hong Kong10,000 participantsStarted Nov 2024

Study of VIR-3434 in Healthy Volunteers and Patients With Chronic Hepatitis B Virus Infection

Treatment Prioritisation and Cost-Effectiveness Analysis for HBV Cure - Real-World Evidence from a Territory-Wide Cohort

Related Searches

Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B (China)

Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

Safety and Immunogenicity of Hecolin® in Healthy Pregnant Women

A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related

Patient-Centered Models of HCV Care for People Who Inject Drugs

A Research Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DUR-928 in Patients With Alcoholic Hepatitis

Lay User Evaluation of the Panbio™ HCV Self-Test

PK of NRL972 in Patients with Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD)

Technical Validation of MR Biomarkers of Obesity-Associated NAFLD

Study of Safety and Tolerability of DCR HBVS

Hepatitis C-Video vs. Brochure Education Delivery

Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus Infection

Screening, Treatment, and Eradication of Hep C

Liver Status and Presence of MASLD/MASH in Patients With Chronic Hepatitis B

Understanding HCV Reinfection Rates in an Incarcerated Population After Cure With Interferon Free HCV Treatment

Ultrasound and Attenuation Imaging